180 Life Sciences CORP 10-Q quarterly reports

Forum Markets, Inc. (formerly ETHZilla Corporation) filed its Form 10-Q for the quarter ended June 30, 2026, detailing a strategic pivot towards digital assets and RWA tokenization, reporting significant net losses and operational changes.

Forum Markets reports a net loss of $76.3 million for Q1 2026 as it transitions to a digital asset and RWA tokenization business model.

ETHZilla Corporation has shifted its core business to an Ethereum-focused treasury strategy, reporting a significant net loss in Q3 2025 despite substantial capital raises and the alleviation of going concern doubts.

180 Life Sciences Corp. reported a significant increase in net loss and cash burn for the first half of 2025, raising substantial doubt about its ability to continue as a going concern, as it pivots from biotechnology to online blockchain gaming.

180 Life Sciences reports a net loss for Q1 2025 while strategically shifting focus to the online gaming industry and managing legacy biotechnology assets.

180 Life Sciences Corp. reports a net loss for Q3 2024 but highlights a strategic move into the iGaming industry with the acquisition of a blockchain casino platform.

180 Life Sciences reported a net income of $11,781 for the second quarter of 2024, a significant improvement compared to a net loss of $3.68 million in the same period last year, while navigating ongoing financial and operational challenges.

180 Life Sciences Corp. reports a reduced net loss for the first quarter of 2024, alongside ongoing strategic evaluations and challenges with Nasdaq listing compliance.